Pulmonext 5mg Tablet contains Ambrisentan 5 mg, an endothelin receptor antagonist (ERA) indicated for the treatment of Pulmonary Arterial Hypertension (PAH). It works by blocking the action of endothelin-1, a naturally occurring substance that causes narrowing of blood vessels, thereby helping to relax the pulmonary arteries, reduce blood pressure in the lungs, and improve exercise capacity.

Manufactured by MSN Laboratories, Pulmonext 5mg is formulated to provide effective management of PAH, helping patients improve their functional status and quality of life when used under medical supervision.

Key Features:

• Contains Ambrisentan 5 mg
• Used in the treatment of Pulmonary Arterial Hypertension (PAH)
• Helps improve exercise tolerance and delay disease progression
• Manufactured by MSN Laboratories
• Prescription-only medication

Important Information:
Pulmonext 5mg Tablet should be taken exactly as prescribed by a healthcare professional. Regular monitoring of liver function, hemoglobin levels, and pregnancy status (where applicable) may be required during treatment. This medicine should not be used during pregnancy due to the risk of serious fetal harm.